About Us


Ophthorobotics was founded in November 2014 and is headquartered in Switzerland. Our team of world class engineers and ophthalmic specialists is passionate about providing a high-tech solution for the delivery of intravitreal injections to treat many chronic ocular diseases.


Ophthorobotics is a Swiss company committed to the development of medical robotics. We aim to provide safe and comfortable treatment to patients, while allowing for economic efficiency through cutting-edge technology.

Meet Our Team


At Ophthorobotics we believe in the best talent, irrespective of location. Our team works as a global network of expertise and passion for healthcare.

Our Team

Miguel Serrano




Miguel, PhD, MBA, isa Global executive who has developed his career in the commercial space across business verticals (Industrial, Energy, Automotive, FMCG), specializing in Healthcare, particularly around how to establish the link between the industry and payers for accelerating the adoption of new therapies and technologies across the world.

Miguel is a recognized entrepreneurial healthcare leader, who has established and developed global teams and functions. He has a recognized track record in helping businesses develop innovative business models, boost revenue and profit, always leaving behind a strong legacy and impactful P&L results. Miguel is also a passionate people leader with focus on developing talent in an inclusive and diverse environment.

As Ophthorobotics' chairman and CEO, he passionate about making a real impact for the 400 Million patients suffering from visual impairment as a result of degenerative retinal diseases, by building a diverse, engaged, inclusive, socially responsible and equally passionate about the company's mission.

Miguel also serves as a member of the Board at Bredam SA and the Professional Pricing Society. He also collaborates with the HLTH Foundation on developing future C-Suite female healthcare leaders.

 Music, cooking, to travel and foremost his family, are his core passions besides healthcare.



Jasan Zughaibi


Jasan Zughaibi MSc Mech. Eng.

Acting CTO; R&D Engineering Leader

Jasan is fully focused on our product development, applying his years of industry experience leveraging his robotics development skills.







Stephan Michels is currently owner of the Augenklinik-West as well as professor at the University of Zurich. He had his training in Ophthalmology at the University of Luebeck, the Emory University Atlanta, the Bascom Palmer Eye Institute, Miami and the Medical University of Vienna. He was the first to report the use of Bevacizumab (AvastinĀ®) in Ophthalmology and is known for his work on therapeutic treatment strategies (e.g. PrONTO Study). He has published more than 70 peer-reviewed articles. Under his guidance the department of Ophthalmology has become the largest single intravitreal injection center in Switzerland and one of the leading centers for clinical studies on macular diseases in Switzerland.



Bradley J. Nelson, Prof.

Scientific Advisor


Bradley J. Nelson has been involved in the development of advanced technology to assist in ophthalmic surgery since 2003. He is leading the MSRL at ETH, which combines advanced robots of different scales with newly developed materials for the field of targeted drug delivery in several parts of the human body. Previously, he has spun off a company that focuses on minimally invasive catheter guidance in the heart and is entering human trials.

Franziska Mathis-Ullrich, Prof.

Advisor, Medical Robotics


Mechanical engineer by training, who specialized in Robotics, Franziska Ullrich has focused on robot-assisted minimally invasive ophthalmic interventions throughout her doctoral studies at ETH Zurich. She has authored numerous publications that focus on the development of cutting-edge technology for ophthalmic interventions. For her work, she has received multiple awards and made it onto the prestigious Forbes "30 under 30" list (Europe). Franziska Ullrich has gained practical experience in several international high-tech industries and research laboratories in Switzerland, Sweden, Australia and China. As co-founder of Ophthorobotics AG, she is highly passionate about the development and commercialization of the first system capable of performing a complete ophthalmic surgical procedure.

Matthias Becker, Prof.

MD, Medical & Regulatory Advisor


Matthias Becker is chair at the department the ophthalmology at City Hospital Triemli Zurich and is professor at University Heidelberg in Germany. Under his leadership the department has become internationally renowned clinic for retinal diseases. He is an acknowledged specialist for intraocular inflammation and vitreoretinal surgery. He has published more 100 peer reviewed articles and has obtained a MSc in healthcare management in 2008.